Results 211 to 220 of about 81,648 (311)

Membrane‐type I metalloproteinase (MT1‐MMP): A key modifier of extracellular matrix microenvironment

The FEBS Journal, EarlyView.
MT1‐MMP: A cellular microenvironment modifier. MT1‐MMP is a major cellular microenvironment modifier, maintaining collagen homeostasis by degrading excess collagen (A), creating a migration path in motile cells such as cancer cells (B), modulating local microenvironmental signaling by cleaving transmembrane receptors (C), and destroying tissue ...
Yoshifumi Itoh, Masaki Inada
wiley   +1 more source

Optimizing <i>in vitro</i> osteoclastogenesis: bone marrow-derived macrophages differentiation and cell density as critical determinants. [PDF]

PeerJ
Li J, Sun X, Yan C, Zhao W, Liu D, Liu Y, Zheng S.   +6 more
europepmc   +1 more source

Intramuscular myxoma with chondroid features: two cases expanding the morphological spectrum

Histopathology, EarlyView.
Background Intramuscular myxoma is a benign mesenchymal tumour typically composed of bland spindle to stellate cells in abundant myxoid stroma and usually characterized by GNAS mutations. Chondroid matrix has not been previously reported in intramuscular myxoma.
Bethany Batson, Azfar Neyaz, Lucas Da Gama Lobo, Rana Naous, Stella J Lee, Ivy John   +5 more
wiley   +1 more source

TSP-1 interaction with RANK and OPG: implications for bone remodeling and osteolytic bone metastasis. [PDF]

Cell Death Dis
Carminati L, Sangalli F, Urbinati C, Longhi E, Tomasoni G, Borsotti P, Midwood KS, Carlessi E, Rusnati M, Taraboletti G.   +9 more
europepmc   +1 more source

Osteoclast [PDF]

, 2020
openaire   +1 more source

Renal function in African women receiving tenofovir disoproxil fumarate as pre‐exposure prophylaxis for HIV during pregnancy and postpartum: A postpartum safety analysis in the CAP016 randomized control trial

HIV Medicine, EarlyView.
Abstract Background The effect of tenofovir disoproxil fumarate (TDF) when used as pre‐exposure prophylaxis (PrEP) on renal function in pregnant and postpartum women is understudied. An open‐label clinical trial (CAP016 study) was designed to examine the safety of TDF‐PrEP use during pregnancy and breastfeeding.
Gaysheen Kistan, Tonya Esterhuizen, Megeshinee Naidoo, Alicia C. Desmond, Motshedisi Sebitloane, Dhayendre Moodley   +5 more
wiley   +1 more source

Geranylgeraniol promotes osteoblast differentiation and inhibits osteoclastogenesis through MAPK and nuclear receptor signaling. [PDF]

J Biol Chem
Tomomura M, Tsukahara T, Suzuki R, Sakagami H, Bandow K, Tomomura A.   +5 more
europepmc   +1 more source

Outcomes of Root Canal Treatment in Patients With Autoimmune Disease: A Retrospective Case–Control Study

International Endodontic Journal, EarlyView.
ABSTRACT Aim The purpose of this study was to compare the outcome of nonsurgical root canal treatment (RCT) in patients with autoimmune diseases (AD) with the outcome in patients without AD. The null hypothesis was: there is no difference in the outcomes of RCT regardless of the patient group. Results were also compared among AD subgroups: inflammatory
Seoyeon Lee, Euiseong Kim, Hoiin Jung, Hyejin Kim, Sunil Kim   +4 more
wiley   +1 more source

Regenerative bone-targeted nanoparticles modulate osteoclast function.

Nanoscale Horiz
Rangasami VK, Moore CJ, Xiao B, Benoit DSW.   +3 more
europepmc   +1 more source

VEGF-D-induced intraosseous lymphangiogenesis drives site-specific heterotopic bone resorption. [PDF]

Proc Natl Acad Sci U S A
Vishlaghi N, Griswold-Wheeler D, Korlakunta S, Vallejo A, Mittal M, Sun Y, Zhao P, Yang YP, Rutkowski JM, Levi B, Dellinger M.   +10 more
europepmc   +1 more source